跳至主要内容
临床试验/ITMCTR1900002680
ITMCTR1900002680尚未招募4 期

Postmarket Research for Two Classical Formulae of Chinese Medicine Based on an Overarching Design

The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • 1. TTH should be at least more than 1 year, at least 2 days per month (unlimited frequency), and at least one attack of TTH should be more than 4 hours;
  • 2. Visual analog scale (VAS) score >= 3cm;
  • 3. The first attack of TTH was before 50 years old;
  • 4. Aged 18-65 years;
  • 5. TCM syndrome differentiation is Qi stagnation and blood stasis;
  • 6. Sign informed consent.

排除标准

  • 1. Migraine;
  • 2. The results of CT scan and TCD in half a year proved to be secondary headache.
  • 3. Having serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system, and psychosis (schizophrenia, epilepsy, alcoholism, anorexia, etc.) or major neuropsychiatric diseases.
  • 4. Laboratory examination showed that the increase of ALT or AST was more than 2 times of the upper limit of normal value, and the increase of creatinine was more than 1.5 times of the upper limit of normal value.
  • 5. Suffering from other severe pain diseases, such as cancer pain;
  • 6. Patients with self rating Anxiety Scale (SAS) greater than 59 or self rating Depression Scale (SDS) greater than 62, or patients with other mental diseases or severe cognitive disorders;
  • 7. May be allergic to the test drug;
  • 8. Planned pregnancy, pregnant and lactating women;
  • 9. Those who are participating in clinical trials of other drugs or have participated in other clinical trials within one month.

研究者

发起方
The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

相似试验

Effect of Xuefu Zhuyu Oral Liquid on Tension-Type... | 临床试验